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Mag is an MRL-derived glomerulonephritis susceptibility
locus that includes the Fcgr2b and Fcgr3 genes encoding the
inhibitory Fc gamma receptor IIB (FccRIIB) and active FccRIII,
respectively. We measured changes in gene balance in three
B6.MRLc1 congenic mouse strains containing the 82-86,
92–100 and 100 cM regions of the MRL chromosome 1. We
found that only the strain that has 92-100 (which includes
Fcgr loci) developed glomerulonephritis. These congenic
mice had splenomegaly, elevated blood urea nitrogen,
anti-dsDNA antibodies and higher urinary albumin excretion
compared to the parental strain C57BL/6(B6). Prior to the
development of glomerulonephritis, large CD3- (T cell) and
B220- (B cell) positive areas were identified in the spleens
of B6.MRLc1(92–100) mice. Both Fc receptors were found
in mesangial and dendritic cells; important sites of
immune-complex clearance and antigen presentation. The
FccRIII-positive areas were more prominent in the congenic
strain. Fcgr2b mRNA was lower in the B6.MRLc1(92–100)
kidney and spleen than in those organs of the B6 mice while
Fcgr3 expression and the Fcgr3 to Fcgr2b mRNA ratio was
higher in the congenic strain kidneys, spleen and thymus
than in those of the B6 prior to and at an early stage of
glomerulonephritis. We conclude that the imbalance of
inhibitory and active Fc gamma receptors influences the
pathogenesis of glomerulonephritis.
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Autoimmune glomerulonephritis (GN) is one of the most
severe complications of systemic lupus erythematosus (SLE).
Several studies have developed congenic mice derived from
autoimmune disease-prone BXSB, NZB, or NZW mice.1
These studies have clarified that the telomeric region
of chromosome 1 (Chr.1) includes several GN-susceptibility
loci such as Bxs3 (71–99 cM), Sle1 (88 cM), and Nba2
(92–94 cM).1 We also created a GN model using B6.MRLc1
(82–100) congenic mice derived from MRL/MpJ widely used
as an autoimmune disease model.2 B6.MRLc1(82–100) has a
GN-susceptibility locus termed MRL autoimmune glomerulo-
nephritis (Mag) that is related with splenomegaly and
increased serum autoantibody levels, as well as glomerular
damage with immune complex (IC) deposits.2
The development and pathological features of GN are
strongly affected by glomerular IC depositions.3–5 The
murine Chr.1 (82–100 cM) includes complex genes for the
Fcg-receptor (FcgR) family composed of low-affinity recep-
tors for the Fc region of IgG with a high affinity for ICs.6,7
The activation of immune responses through mouse FcgR is
caused by binding of ICs containing IgG to active FcgRs such
as FcgRIII.6–8 Mouse FcgRIII is encoded by Fcgr3 localizing
on Chr.1 (92.3 cM) and is similar to human FcgRIII in
transmembrane/cytoplasmic regions, whereas its extracellular
regions show homology to human FcgRII rather than
FcgRIII, and this receptor has a common g-chain linking
to immune-receptor tyrosine-based activation motif.6,7,9,10
On the other hand, these activated immune responses are
inhibited by FcgRIIB coded by Fcgr2b on Chr.1 (92.3 cM),
with an immune-receptor tyrosine-based inhibition motif
and high homology to human FcgRIIB.6,7,11 These FcgRs are
prone to bind mouse IgG1- and IgG2-containing ICs rather
than IgG3.6,7
Recent genome-wide linkage screenings for human SLE
have shown significant linkage to Chr.1q23, including the
FcgR genes.12,13 Furthermore, various FcgR-gene polymor-
phisms affect the pathogenesis of human SLE,14–16 and some
studies have reported that 158-V/F polymorphism in the
FcgRIIIA extracellular domain affected IgG binding affinity
and was a risk factor for SLE.17,18 On the other hand, Hatta
et al.19 reported that significant differences were detected
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between FcgRIIIB-NA1/2 polymorphism and lupus nephritis
patients. In animal models, several studies have assessed
the role of FcgRs in GN by using FcRg-chain-deficient mice,
mice lacking active FcgRs, or FcgRIIB-deficient mice.20–23
Briefly, GN of FcRg-chain-deficient mice with the lupus-
prone NZB/W F1 background was ameliorated as compared
with that of NZB/W F1 (gþ /–) mice.21 In addition, Bolland
et al. reported that FcgRIIB-deficient mice with a C57BL/6
background exhibited severe GN.20 From these studies it
has been found that the altered physiological functions of
inhibitory and active FcgRs appear to have crucial roles in
the GN development.
In this study, we generated congenic mice containing the
MRL-FcgR-gene locus and demonstrated the altered balance
of FcgRIIB and FcgRIII in the kidney and immune organs in
this model. Our findings indicate that the imbalance of active
and inhibitory FcgRs is closely associated with the patho-
genesis of GN and should help in the development of new
strategies for diagnosis and therapy targeting these receptors.
RESULTS
MRL-derived congenic strains
Figure 1 illustrates the telomeric region of Chr. 1 and presents
the gene names and genetic distances based on the Mouse
Genome Database. In the three strains that were produced,
only B6.MRLc1(92–100) contains the MRL-derived Fcgr
locus.
Glomerulonephritis in B6.MRLc1(92–100)
Figure 2 shows light micrographs of the glomerulus from
the C57BL/6 and congenic strains. B6.MRLc1(82–86) and
B6.MRLc1(100) mice exhibited the normal glomerular struc-
ture as C57BL/6 mice (Figure 2a–c). In contrast, B6.MRLc1
(92–100) mice exhibited glomerular damage mainly invol-
ving mild cell proliferation at 6 months (Figure 2d). These
glomerular lesions had clearly deteriorated with age, and
12-month-old B6.MRLc1(92–100) mice exhibited proli-
ferations of the endothelial and mesangial cells (MCs) and
expansion of the mesangial matrix (Figure 2e and f). Certain
glomeruli of B6.MRLc1(92–100) mice revealed severe damage
with global depositions of periodic acid–Schiff-positive mate-
rials and disappearances of capillary and capsular lumina
(Figure 2e). Periodic acid-methenamine silver staining
revealed membranous lesions such as spike-like alternations
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Figure 1 | Representation of the telomeric region of Chr.1
in MRL-derived congenic mice. The upper row shows the
B6.MRLc1(82–100) congenic mice produced using Mag markers
that were reported previously.2 The three new congenic strains
developed in the present study are presented in the subsequent
rows: B6.MRLc1(82–86), B6.MRLc1(92–100), and B6.MRLc1(100).
The microsatellite markers used for genotyping and their
positions (cM) are indicated at the top. The MRL-type congenic
intervals are represented by black boxes. Some immune- or cell
proliferation-associated genes associated with congenic intervals,
such as the Fas ligand (Fasl), selectin endothelial (Sele), selectin
lymphocyte (Sell), selectin platelet (Selp), Fcg receptor (Fcgr),
and exonuclease1 (Exo1), are indicated at the bottom.
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Figure 2 | Light micrographs of the renal cortices from C57BL/6 and MRL-derived congenic mice. Twelve-month-old female C57BL/6
mice (a), 8-month-old female B6.MRLc1(82–86) mice (b), 8-month-old female B6.MRLc1(100) mice (b), 6-month-old female B6.MRLc1
(92–100) mice (d), 12-month-old female B6.MRLc1(92–100) mice (e–h). B6.MRLc1(82–86) and B6.MRLc1(100) mice have normal renal
structures similar to C57BL/6 mice, and their glomeruli present no histopathological changes (a–c). B6.MRLc1(92–100) mice exhibit
proliferative glomerular lesions that mainly comprise proliferation of mesangial cells and expansion of mesangial matrices, and these lesions
deteriorate with age (d–f). Glomeruli of B6.MRLc1(92–100) mice at 12 months reveal membranous lesions such as thickening of the
glomerular basement membrane, spike-like alternations, and a double contour of glomerular basement membrane (arrows, g, h). Certain
glomeruli of B6.MRLc1(92–100) mice exhibit global deposition of periodic acid–Schiff-positive material and disappearance of capillary
and capsular lumina (e). Periodic acid–Schiff- (a–f) and periodic acid–methenamine silver-stained (g, h) cortices. Bars¼ 20mm.
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or double contour of glomerular basement membranes in
12-month-old B6.MRLc1(92–100) mice (Figure 2g and h).
Immunofluorescence revealed glomerular IgG-containing
IC deposits in B6.MRLc1(92–100) mice (Figure 3). IgG1-
and IgG2b-positive reactions were mainly observed in the
glomerular mesangial regions of B6.MRLc1(92–100) mice;
however, these reactions were considerably few in the C57BL/6
strain.
The glomerular damage in the B6.MRLc1(92–100) strain
was also assessed histometrically (Figure 4a and b). Briefly, at
6 and 12 months of age, that is, at the early and late GN
development stages reported for B6.MRLc1(82–100) mice,2
the diameter of the renal corpuscle and the numbers of nuclei
in the glomeruli were measured as indices for the degree of
glomerular hypertrophy and proliferative lesions, respec-
tively. B6.MRLc1(92–100) mice had significantly higher
values of renal corpuscle diameter than mice of the
C57BL/6 strain, at 12 months (Figure 4a), and the numbers
of nuclei in glomeruli was high in B6.MRLc1(92–100) mice
at both ages (Figure 4b).
Measurement of serum creatinine and blood urea nitrogen
level and urinary albumin detection were performed for
6- and 12-month-old mice. No significant differences
were observed in creatinine levels, but B6.MRLc1(92–100)
mice tended to show higher values than C57BL/6 mice at
12 months of age (Figure 4c). B6.MRLc1(92–100) mice had
higher blood urea nitrogen levels than C57BL/6 at both ages,
and significant differences were observed at 12 months of age
(Figure 4d). Albumin was detected in the urine samples by
sodium dodecyl sulfate (SDS)-polyacrylamide gel electro-
phoresis. Using bovine serum albumin as the control, the
urine protein fraction of approximately 66 kDa was deter-
mined to be the albumin fraction. The albumin band was
identified in both the strains; however, B6.MRLc1(92–100)
mice, especially at 12 months, exhibited strong albumin
excretions as compared with C57BL/6 mice (Figure 4e).
Activation of immune system in B6.MRLc1(92–100) mice
Figure 5a and b shows the spleen weights and serum levels of
anti-double-stranded DNA (dsDNA) antibodies (Abs) of
C57BL/6 and B6.MRLc1(92–100) mice at 6 and 12 months of
age, respectively. B6.MRLc1(92–100) mice exhibited signi-
ficantly higher values of spleen weights at 12 months of
age than C57BL/6 mice and also had higher serum levels
of anti-dsDNA Abs at both 6 and 12 months of age.
Figure 5c–f illustrates the immunohistochemistry for
CD3 (T-cell marker) and B220 (B-cell marker) at 1 month
when no histological renal changes were observed in
B6.MRLc1(92–100) mice. CD3- and B220-positive areas were
observed in the periarteriolar lymphatic sheath and splenic
a b
c d
Figure 3 | Direct immunofluorescence on cryostat sections
for detecting IgG subtypes in glomeruli from 6-month-old
C57BL/6 and B6.MRLc1(92–100) mice. The sections were
analyzed by confocal microscopy. IgG1-positive reactions
are visualized using FITC-conjugated antibodies (green, a, c).
IgG2b-positive reactions are visualized using tetramethyl
rhodamine isothiocyanate-conjugated antibodies (red, b, d).
Clear immunoreactions of IgG1 and IgG2b are observed in the
mesangial regions of a 6-month-old B6.MRLc1(92–100) mouse
(c, d); however, these reactions are very weak in corresponding
C57BL/6 mice of the same age (a, b). Bars¼ 20mm.
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Figure 4 | Comparison of the indices for GN between C57BL/6
and B6.MRLc1(92–100) mice at 6 and 12 months of age.
(a) Diameter of the renal corpuscle. (b) Number of nuclei present
in the glomeruli. (c) Serum levels of creatinine. (d) Serum levels
of blood urea nitrogen. Each value represents the mean±s.e.
* Significantly different from C57BL/6 mice of the same age
(Mann–Whitney U-test, Po0.05); nX3. (e) Detection of
urinary albumin. We analyzed 3 ml of urine from C57BL/6
and B6.MRLc1(92–100) mice by SDS-polyacrylamide gel
electrophoresis. As control, 1 mg of bovine serum albumin
was used.
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lymphoid follicles, respectively. Spleen weights of both the
strains did not differ significantly at 1 month of age (C57BL/
6: 49±0.4 mg and B6.MRLc1(92–100): 52±0.2 mg), whereas
these immune-positive areas were more widely observed
in B6.MRLc1(92–100) than in C57BL/6 mice (Figure 5 c–e).
These observations were confirmed by histometric analysis
for measurement of CD3- and B220-positive areas in the
spleen. B6.MRLc1(92–100) mice had significantly higher values
of each parameter than C57BL/6 mice (Figure 5g and h).
Localizations of FccRs
In the kidney, FcgR-positive reactions were mainly observed
in the glomerular mesangial regions in both C57BL/6
and B6.MRLc1(92–100) mice (Figure 6a, b, g, and h). Interes-
tingly, although intensity of FcgRIIB-positive reactions was
similar among strains (Figure 6a and g), FcgRIII-positive
reactions were strongly observed in B6.MRLc1(92–100) mice
(Figure 6b and h). In the spleen, reticular FcgR-positive
reactions were mainly observed in the germinal centers of
splenic lymphoid follicles, and these reactions morpho-
logically appeared to represent the cytoplasmic processes of
dendritic cells (DCs) (Figure 6c, d, i, and j). Indeed, double
staining for FcgRIII and CD11c used as the DC markers
demonstrated colocalization of these materials (Figure 7a).
Similar to those in the kidney, FcgRIII-positive reactions
in splenic lymphoid follicles were stronger in B6.MRLc1
(92–100) mice (Figure 6d and j). In the thymus, FcgRIIB-
positive reactions represented a single cell that was localized
at the boundary between the thymic cortex and medulla
(Figure 6e and k), and the reaction intensities were similar
among strains. On the other hand, FcgRIII-positive cells
could only be detected in B6.MRLc1(92–100) mice, and the
morphological features of these cells were similar to FcgRIIB-
positive cells that had elliptic nuclei and processed cytoplasm
(Figure 6e, k, and l). In the double staining for FcgRIII and
CD11c, these localizations appeared to be were fused and
merged yellow (Figure 7b).
mRNA expressions of Fcgrs
Figure 8 shows the mRNA expressions of the FcgR genes
and b-actin in the kidney, spleen, and thymus of B6.MRLc1
(92–100) and C57BL/6 at mice 1 month. Fcgr2b expression
was observed in three organs in both the strains, and no
difference in the expression intensity was observed among
strains (Figure 8, upper lane). On the other hand, although
Fcgr3 expression was also detected in three organs of both
the strains, the intensity of expression was stronger in
B6.MRLc1(92–100) and weaker in C57BL/6 mice.
Figure 9 shows the results of quantitative real-time PCR
analysis for relative Fcgr2b and Fcgr3 mRNA expression levels
in the kidney, spleen, and thymus at the non-GN develop-
ment stage (1 month) and early GN development stage
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Figure 5 | Comparisons of the indices for development of autoimmune disease between C57BL/6 and B6.MRLc1(92–100) mice.
(a) Spleen weight. (b) Serum levels of anti-dsDNA antibody. Each value represents the mean±s.e. * Significantly different from C57BL/6
mice of the same age (Mann–Whitney U-test, Po0.05); nX3. (c–f) Immunohistochemical detection of CD3- and B220-positive cell areas in
spleens obtained from 1-month-old C57BL/6 and B6.MRLc1(92–100) mice. CD3- and B220-positive areas were mainly observed in the
periarteriolar lymphatic sheath and splenic lymphoid follicles, respectively. Notably, both CD3- and B220-positive cell areas in
B6.MRLc1(92–100) mice (d, f) are more widely observed than in C57BL/6 mice (c, e). Bars¼ 100 mm. (g, h) Histometric analysis for
CD3- and B220-positive areas in spleens at 1 month of age. Each value represents the mean±s.e. * Significantly different from C57BL/6
(Mann–Whitney U-test, Po0.05) mice; nX5.
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(6 months). At 1 month, Fcgr2b levels in the kidney and
spleen were significantly lower in B6.MRLc1(92–100) than in
C57BL/6 (Figure 9a) mice. In contrast, the Fcgr3 levels in the
three organs were significantly higher in B6.MRLc1(92–100)
than in C57BL/6 (Figure 9b) mice. At 6 months, Fcgr2b levels
in the kidney and spleen tended to be lower in B6.MRLc1
(92–100) than in C57BL/6 mice; however, the reverse was true
in the case of the thymus (Figure 9c). On the other hand,
Fcgr3 levels in three organs were significantly higher in
B6.MRLc1(92–100) than in C57BL/6 (Figure 9d) mice.
Figure 10 shows the ratio of relative mRNA expression
of Fcgr3 to that of Fcgr2b in 1- and 6-month-old B6.MRLc1
(92–100) and C57BL/6 mice. The values are expressed as fold
increases as compared with those in C57BL/6 mice. At
1 month, B6.MRLc1(92–100) mice exhibited higher values
than C57BL/6 in three organs, with the largest difference in
the thymus (Figure 10a). At 6 months, a similar tendency was
observed for three organs, and the values in B6.MRLc1
(92–100) mice were markedly higher than those in C57BL/6
mice in the kidney and spleen (Figure 10b).
DISCUSSION
MRL-Chr. 1 (82–100 cM) includes GN-susceptibility locus
termed Mag.2 In this study, we produced three congenic
strains including Mag regions (82–86, 92–100, 100 cM) to
confirm the contributions of the FcgR-gene locus to GN
development. Previous studies have demonstrated that Fasl
a b c d e f
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Figure 6 | Indirect immunofluorescence on cryostat sections for the detection of FccIIB and FccRIII in 6-month-old mice. Kidney
(a, b, g, h), spleen (c, d, i, j), and thymus (e, f, k, l). The sections are analyzed by confocal microscopy. FcgRIIB-positive reactions are visualized
using an anti-mouse FcgRIIB primary antibody and FITC-conjugated secondary antibody (green, a, g, c, i, e, h). FcgRIII-positive reactions
are visualized using an anti-mouse FcgRIII primary antibody and tetramethyl rhodamine isothiocyanate-conjugated secondary antibody
(red, b, h, d, j, f, l). In the kidney, FcgRIIB-positive and FcgRIII-positive reactions are observed in the glomerular mesangial regions in C57BL/6
(a, b) and B6.MRLc1(92–100) mice (g, h), and the intensity of the FcgRIII-positive reaction in B6.MRLc1(92–100) mice (h) is stronger than that
in C57BL/6 mice (b). In the spleen, reticular FcgRIIB- and FcgRIII-positive reactions are observed in the germinal centers of the splenic lymph
follicles in C57BL/6 (c, d) and B6.MRLc1(92–100) mice (i, j), and the intensity of FcgRIII-positive reactions in B6.MRLc1(92–100) mice (j) is
stronger than that in C57BL/6 mice (d). In the thymus, FcgRIIB-positive reactions represent a single cell that localized on the boundary
between the thymic cortex and medulla, and has elliptic nuclei and processed cytoplasm (e, k). FcgRIII-positive cells are observed in
B6.MRLc1(92–100) mice exclusively and the morphological features of these cells resemble those of FcgRIIB-positive cells (l). Bars¼ 20mm.
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Figure 7 | Double immunofluorescence on cryostat sections
for detection of CD11c and FccRIII in 6-month-old
B6.MRLc1(92–100) mice. Spleen (a) and thymus (b). The sections
are analyzed by confocal microscopy. CD11c-positive reactions are
visualized using an anti-mouse CD11c primary antibody and
FITC-conjugated secondary antibody (green). FcgRIII-positive
reactions are visualized using an anti-mouse FcgRIII primary
antibody and tetramethyl rhodamine isothiocyanate-conjugated
secondary antibody (red). In spleen, reticular CD11c-positive and
FcgRIII-positive reactions are shown to be colocalized (yellow, a).
In the thymus, the immune-positive reactions of FcgRIII and
CD11c are fused in a cell having processed cytoplasm (yellow, b).
Bars¼ 20 mm.
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Figure 8 | Reverse transcriptase-PCR analysis for Fcgr2b, Fcgr3,
and b-actin mRNA expression in the kidney, spleen, and
thymus of 6-month-old B6.MRLc1(92–100) and C57BL/6 mice.
Upper lane (Fcgr2b), middle lane (Fcgr3), and bottom lane
(b-actin). Size markers are represented on the left (n¼ 2).
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(85.0 cM) deficiencies mediating apoptosis and the selectin
family (86.6 cM) relating to cellular adhesion led to GN in the
autoimmune disease-prone mouse.24,25 Furthermore, Exo1
(100 cM), which is involved in DNA repair, was suggested as
a candidate gene for testicular apoptosis in MRL/MpJ.26
However, histopathological examinations demonstrated that
only B6.MRLc1(92–100) exhibited glomerular damage. In
addition, B6.MRLc1(92–100) mice revealed glomerular IC
depositions, slight aggravation of renal function, and increa-
sed spleen weights and autoantibody levels. From these
findings, it was clarified that B6.MRLc1(92–100) mice had
autoimmunity-mediated glomerular damage and confirmed
that MRL-Chr.1 (92.3–100 cM), including the FcgR-gene
locus, but not other Mag regions such as Fasl, selectin family,
or Exo1, was crucial for development of GN.
In this study, FcgR-positive reactions were observed in the
glomerular mesangial regions. Glomerular MCs participate in
the regulation of glomerular filtration rate and in glomerular
pathogenesis.27,28 Activated MCs produce various inflamma-
tory mediators 29,30 Radeke et al.31 demonstrated that normal
murine MCs mainly expressed FcgRII rather than FcgRIII,
and that stimulation, such as interferon-g, caused down-
regulation of FcgRII, with activation of FcgRIII, inducing
production of chemokines such as monocyte chemo-
attractant protein-1 in MCs. Our results were consistent
with these reports: B6.MRLc1(92–100) exhibited stronger
FcgRIII-positive reactions than C57BL/6 mice, and Fcgr2b
downregulation and Fcgr3 upregulation were observed in
the kidneys. From these findings, it was considered that
the altered balance of FcgRs in MCs might contribute to the
pathogenesis of GN in B6.MRLc1(92–100) mice through
alterations in the conditions of local glomerular chemokine
or cytokine production.
In the spleen and thymus, FcgR-positive cells were identi-
fied as DCs by immunofluorescence. Similar to that observed
in the kidney, B6.MRLc1(92–100) mice had stronger FcgRIII-
positive reactions and higher Fcgr3 to Fcgr2b ratios as com-
pared with C57BL/6 mice in these organs. Recent studies
suggested that FcgRs on DCs mediate phagocytosis and
antigen presentation associated with maturation of DCs
and stimulation of T cells.32,33 Desai et al.32 suggested that
FcgRIIB was required for peripheral tolerance through
inhibition of DC activation or limiting antigen processing.
Furthermore, Boruchov et al.34 demonstrated that the altered
balances of inhibitory and active FcgRs in human DCs
induced production of cytokines such as tumor-necrosis
factor-a, and concluded that coexpression of these FcgRs in
DCs was associated with tolerance or immunity by ICs.
Interestingly, in the kidney, MCs had immunological
functions similar to DCs, and it was suggested that activated
MCs expressed major histocompatibility complex-II and
intercellular adhesion molecule-1, and could function as
antigen-presenting cells, and that they directly contacted
lymphocytes.35,36 Therefore, the altered balance of FcgRs
in immunological principal-function units, such as DCs or
MCs, may contribute to the pathogenesis of GN by causing
disruption of immune functions such as antigen presentation
or IC clearance through over-activation of these cells.
Interestingly, from the results of immunohistochemistry
for CD3 and B220, it was suggested that activation of
immune system in B6.MRLc1(92–100) mice was caused
before development od GN. Furthermore, in the non-GN
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Figure 9 | Comparison of relative Fcgr2b and Fcgr3 mRNA
expression in the kidney, spleen, and thymus among 1- and
6-month-old B6.MRLc1(92–100) and C57BL/6 mice by
quantitative real-time PCR analysis. (a) Fcgr2b at 1 month
of age. (b) Fcgr3 at 1 month of age. (c) Fcgr2b at 6 months of age.
(d) Fcgr3 at 6 months of age. Each value of Fcgr2b and Fcgr3 is
normalized by that of b-actin and represents the mean±s.e.
*Significantly different from C57BL/6 mice (Mann–Whitney U-test,
Po0.05); nX3.
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Figure 10 | The ratios of relative mRNA expression of Fcgr3 to
that of Fcgr2b in 1- and 6-month-old B6.MRLc1(92–100) and
C57BL/6 mice. (a) 1 month of age. (b) 6 months of age. Raw
values of Fcgr2b and Fcgr3 are normalized by that of b-actin and
are expressed as fold increases compared with C57BL/6 mice.
Each value represents the mean±s.e. (nX3).
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development stage, the balance of Fcgr expressions was clearly
altered in the immune organs of B6.MRLc1(92–100) mice.
Previous studies have reported the role of FcgRIIB in the
negative selection of lymphocytes and suggested that B cells
expressed FcgRIIB, and hypermutated B cells were eliminated
by FcgRIIB-dependent apoptosis triggered by DC-bound
ICs.6 In addition, Durum et al.37 reported that FcgRIII on
embryonic thymocytes played an important role in T-cell
development, on the basis of data demonstrating that anti-
FcgRIII Abs treatment blocked rearrangement of the T-cell
receptor-b locus and T-cell development. Although we could
not assess the interactions between FcgRs and lymphocytes,
the relationships between the functional deficiency of FcgRs
in the juvenile period and the production of autoreactive
lymphocytes might be associated with the innate autoim-
mune disease-prone trait.
Recently, Fcgr2b promoter-region polymorphisms, which
cause a reduction in the gene transcription, were reported in
autoimmune disease-prone strains, including MRL.38
Furthermore, a recent study suggested that some SLE patients
exhibited decreased FcgRIIB-gene transcriptions mediated by
343 G/C promoter-region polymorphism.39 Indeed, Fcgr2b
levels were lower in B6.MRLc1(92–100) than in C57BL/6
mice in the non-GN development stage. Therefore, it was
considered that one of the causes of Fcgr imbalances was
Fcgr2b promoter-region polymorphism. However, Fcgr3
upregulation was more severe than Fcgr2b downregulation
in B6.MRLc1(92–100) mice. Clynes et al.21 reported that in
FcRg-chain-deficient mice with a GN-prone background,
lacking active FcgRs, glomerular inflammation was pre-
vented; however, the amount of glomerular IC depositions
was not altered. Fujii et al.40 suggested that FcgRIII-deficient
mice exhibited resistance to anti-glomerular basement
membrane GN, and FcgRIII played a predominant role in
the induction of glomerular damage. From these findings, it
can be stated that FcgRIII activation is ultimately essential
for the glomerular inflammatory cascade in murine GN.
However, the apparent contradiction exists between the
human and mouse concerning the role of FcgRIII in GN.
The more functional form of FcgRIII would be expected
to promote autoimmune GN in mouse, whereas the less
functional form is associated with human SLE. Briefly, it was
suggested that FcgRIIIA 158-V/F polymorphism, especially
158-F allele, which caused decrease of IC-binding ability, was
linked to the development of human SLE.17,18 On the basis of
these findings, in murine GN models, the changes in the
FcgR balances, rather than those in the IC-binding ability,
can be said to have a great impact on the development of GN.
The murine Chr.1 (92–100 cM) contains not only FcgR
genes but also other immune- and cell proliferation-
associated genes. Crp (94.2 cM) and Apcs (94.2 cM) code
C-reactive protein and serum amyloid P component. Interes-
tingly, it has been suggested that C-reactive protein and
serum amyloid P component recognize ligands from apop-
totic cells, bind to FcgRs, and play important roles in presen-
tation and clearance of self-antigen.41 Furthermore, it was
reported that serum amyloid P component-deficient mice
developed GN and that C-reactive protein administration to
NZB/W F1 induced their prolonged survival and decreased
autoantibody levels.42,43 On the other hand, it was reported
that the Ifi202 (95.2 cM) promoter-region polymorphism
correlated with the contribution of Nba2 to lupus, and MRL
has a polymorphism in this region similar to that of
NZB.44,45 Thus, not only FcgR genes, but also other genes
in Chr.1 (92–100 cM), might be associated as initiators or
accelerators with GN of B6.MRLc1(92–100) mice.
In conclusion, we demonstrated that B6.MRLc1(92–100)
mice having the MRL-FcgR-gene locus clearly presented with
GN. It was clarified that the balance of inhibitory FcgRIIB
and active FcgRIII, localizing glomerular mesangial regions
and DCs, was remarkably altered in the kidney and immune
organs of B6.MRLc1(92–100) mice. We propose that the
imbalances of inhibitory and active FcgRs hold a key in
elucidating the pathogenesis of GN.
MATERIALS AND METHODS
Generation of congenic mice
B6.MRLc1(82–100) were generated as reported by Ichii et al.,2 and
C57BL/6 were purchased from an animal-breeding company (Japan
SLC Inc., Hamamatsu, Japan) and maintained under conventional
conditions. For care and handling of experimental animal, the
investigators adhered to the ‘Guide for the Care and Use of Animals’
by the School of Veterinary Medicine, Hokkaido University. The
F1 generation was produced by crossing C57BL/6 with
B6.MRLc1(82–100) mice and backcrossed with C57BL/6 mice to
produce the N2 generations. N2 animals were typed for six
microsatellite markers D1mit202–403 (Figure 1). The map positions
of the microsatellite loci were based on the Mouse Genome
Database. Polymorphisms between congenic strains and C57BL/6
were detected by a PCR-based method.2 Heterozygotes for three
regions (81.6–86.6, 92.3–100, and 100 cM) were bred to C57BL/6
mice to produce N3 generations. Finally, three MRL-type homo-
zygous mice designated B6.MRLc1(82–86, 92–100, and 100) were
created and maintained from 5 to 10 generations by further
inbreeding and were used in the experiments.
Tissue preparation for histological studies
Under deep anesthesia, mice were killed by exsanguination from
carotid arteries, and the kidneys, spleens, and thymuses were
immediately removed at 1–12 months. A part of each sample was
fixed in 10% formalin at room temperature for histopathological
analysis and immunohistochemistry. The remaining part was frozen
in liquid nitrogen after OCT compound embedding (Tissue-tek;
Sakura Finetek, Torrance, CA, USA) and stored at 80 1C for
immunofluorescence.
Histopathological analysis
To assess the severity of glomerular damage, paraffin sections (2 mm)
from 6- and 12-month-old mice were stained with periodic
acid–Schiff. Digital images of 30 glomeruli per kidney were prepared
and the number of nuclei per glomerulus and the diameters of
renal corpuscles were measured using Adobe Photoshop version
6.0 (Mountain View, CA, USA). A part of the paraffin sections
obtained from 12-month-old mice was stained with periodic
acid–methenamine silver for detection of membranous lesions.
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Immunohistochemistry
Immunohistochemistry for CD3 and B220 in the spleen paraffin
sections was performed using unlabeled rabbit anti-CD3 Ab (Dako,
Kyoto, Japan) and rat anti-B220 Ab (Cedarlane Laboratories,
Homby, Ontario, Canada), as described previously.2 The CD3-
and B220-positive areas in the spleen sections were measured in
1-month-old mice. Briefly, using ImageJ version 1.32j (NIH,
Bethesda, MD, USA), more than 35 CD3- or B220-positive absolute
areas per animal were measured on digital images of spleen obtained
with a digital camera, and the mean of each area was compared
between C57BL/6 and B6.MRLc1(92–100) mice.
Immunofluorescence
We treated 4-mm thick cryosections with goat fluorescein isothio-
cyanate (FITC)-labeled anti-IgG1 Ab and tetramethyl rhodamine
isothiocyanate-labeled anti-IgG2b Ab (Caltag Laboratories, South San
Francisco, CA, USA) diluted to 1:100 for 2 h at room temperature.
Further, the cryosections were treated with unlabeled rat anti-FcgRIIB
Ab and goat anti-FcgRIII Abs (R&D Systems, Minneapolis, MN,
USA) diluted to 1:200 for 2 h at room temperature. The FcgRIIB and
FcgRIII sections were incubated with undiluted FITC-conjugated
goat anti-rat IgG Ab and tetramethyl rhodamine isothiocyanate-
conjugated rabbit anti-goat IgG Ab (Zymed, South San Francisco, CA,
USA), respectively, diluted to 1:100. For double staining for FcgRIII
and CD11c, sections were incubated with hamster anti-CD11c Ab
(Chemicon, Temecula, CA, USA) diluted to 1:200 and FITC-
conjugated rabbit anti-hamster Ab (Southern Biotechnology Associa-
tion, Birmingham, AL, USA) diluted to 1:100 according to the same
protocol as that used for FcgRs after the FcgRIII-staining procedure.
These sections were examined by confocal microscopy.
Serological analysis and urinalysis
The serum levels of creatinine, blood urea nitrogen, and anti-dsDNA
Abs were determined using BUN-test-Wako (Wako Pure Chemical
Industries, Osaka, Japan), the Creatinine Assay kit (Cayman
Chemical, Ann Arbor, MI, USA), and the mouse anti-dsDNA Ab
ELISA kit (Alpha Diagnostic International, San Antonio, TX, USA)
according to the manufacturer’s directions. Urinary albumin was
detected by SDS-polyacrylamide-gel electrophoresis. We heated 3 ml
of urine and 1 mg of bovine serum albumin at 65 1C for 5 min in 2
SDS sample buffer (100 mM Tris-HCl, pH 6.8, 20% glycerol, 4%
SDS, 0.02% bromophenol blue, 12% 2-mercaptoethanol) and
loaded on 12% polyacrylamide gel (e-PAGEL; ATTO Corporation,
Tokyo, Japan). Electrophoresis was performed at 150 V in Tris-
glycine buffer (25 mM Tris, pH 8.3, 192 mM glycine) containing 0.1%
SDS for 2 h. Gels were stained with Quick CBB PLUS (Wako Pure
Chemical Industries).
Reverse transcriptase-PCR and quantitative real-time PCR
To examine the mRNA expressions of Fcgr2b, Fcgr3, and b-actin,
total RNAs were obtained from the kidneys, spleens, and thymuses
of 1- and 6-month-old C57BL/6 and B6.MRLc1(92–100) mice using
TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Purified total
RNAs were treated with DNase for DNA digestion (Nippon Gene,
Toyama, Japan) and cDNAs were synthesized using ReverTra Ace
(Toyobo, Osaka, Japan) and Oligo-dT primer (Invitrogen). PCR for
amplification was carried out with ExTaq (Takara, Tokyo, Japan)
under the following conditions: 5 min at 95 1C, 35 cycles of 40 s at
95 1C, 30 s at 58 1C, and 30 s at 72 1C followed by 5 min at 72 1C. The
details of the specific primers used for each gene are provided in
Table 1.
Quantitative real-time PCR analysis was performed using
Brilliant SYBR Green QPCR Master Mix and real-time thermal
cycler (MX 3000; Stratagene, Milano, Italy) to obtain cDNAs. The
specific primers for each gene were the same as those used for
reverse transcriptase-PCR. The amplification conditions were as
follows: 10 min at 95 1C, 40 cycles of 10 s at 95 1C, 20 s at 58 1C, and
20 s at 72 1C, one cycle of 10 s at 95 1C, 20 s at 58 1C, and 20 s
at 95 1C. ROX dye was included in each reaction to normalize
non-PCR-related fluctuations in the fluorescence signals. The
amplification specificity of all the PCR reactions was confirmed by
melting-curve analysis. Non-template controls were included for each
primer pair to assess any significant levels of contaminants. Quanti-
tative data of Fcgrs were normalized to b-actin expression. The ratio
of Fcgr3 to Fcgr2b was calculated from these normalized values
and expressed as fold increases compared with those of C57BL/6.
Statistical analysis
Results were expressed as mean±s.e. and statistically analyzed by
the non-parametric Mann-Whitney U-test (Po0.05).
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